Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination

The coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidem...

Descripción completa

Detalles Bibliográficos
Autores principales: Molina-Ramos, Ana I., Gómez-Moyano, Elisabeth, Rodríguez-Capitán, Jorge, Angullo-Gómez, María, Gallardo-Jiménez, Patricia, Pérez de Pedro, Iván, Valiente de Santis, Lucía, Pérez-Villardón, Beatriz, Piñero-Uribe, Isabel, Mora-Robles, Javier, Becerra-Muñoz, Víctor Manuel, Jiménez-Navarro, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738968/
https://www.ncbi.nlm.nih.gov/pubmed/36498573
http://dx.doi.org/10.3390/jcm11236999
Descripción
Sumario:The coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidemiology and prognosis of myocarditis related to COVID-19 are currently unknown. While vaccination against COVID-19 is of great benefit at a public health level, the risk of myocarditis should be considered in the context of the global benefits of vaccination. In this narrative review, we will summarize the etiopathogenic bases, the epidemiology, the clinical manifestations, the course, diagnosis, prognosis, and the treatment of myocarditis related to SARS-CoV-2, as well as myocarditis secondary to mRNA vaccines.

Ejemplares similares